Navigation Links
Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting
Date:10/25/2007

All Doses of VYVANSE Studied Demonstrated Significant Efficacy Within One

Week of Daily Treatment

BOSTON, Oct. 25 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, today announced the results of a study which demonstrated that adults with Attention Deficit Hyperactivity Disorder (ADHD) experienced significant improvements in ADHD symptom control within one week of treatment with once- daily VYVANSE(TM) (lisdexamfetamine dimesylate), the first prodrug stimulant. Findings from this phase III pivotal trial were presented today at a national psychiatric meeting in Boston, Mass.

"Adults with ADHD may experience significant impairments in their ability to focus, and organize and complete tasks, which could affect their work, family life and personal relationships," said Lenard A. Adler, M.D., lead researcher in this study and director of the Adult ADHD Program at New York University School of Medicine and author of Scattered Minds: Help and Hope for Adults with ADHD. "The results of this study demonstrated that VYVANSE significantly improved the core symptoms of ADHD in adult study patients."

Results of Phase III Pivotal Trial

In this double-blind, placebo-controlled, four-week study with dose escalations in 414 adults aged 18 to 55 years, treatment with VYVANSE at all doses studied (30 mg, 50 mg, 70 mg) was significantly more effective than placebo and improvements were observed in the first week of the study.

All doses of VYVANSE showed significant improvements in the average change in ADHD Rating Scale (ADHD-RS-IV) scores, as measured from the study's start to end, the primary endpoint of this study. ADHD-RS-IV is a standardized, validated test for assessing symptoms of ADHD and for assessing their response to treatment. The scale, which contains 18 items, is based on the ADHD diagnostic criteria as defined in the Diagnostic and Statisti
'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
2. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
6. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
7. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 OpportunityAnalyzer: Cushing,s Syndrome - Opportunity ... GlobalData estimates that the 2013 sales for the ... across the 6MM covered in this report. Pharmaceutical ... time, and financial resources in the CS field, ... (R&D) strategies. One notable example is the fact ...
(Date:5/27/2015)... May 27, 2015 ... has announced the addition of the  "2015 ... Market"  report to their offering. ... issues pertaining to the US NAT laboratory ... demographic, social and technological trends with significant ...
(Date:5/27/2015)... Research and Markets ( ... the  "US Cancer Vaccine Market Outlook 2020" ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,Cancer vaccines ... categories of prophylactic (preventive) and therapeutic (treatment) ... both of these groups have been marketed ...
Breaking Medicine Technology:OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 2OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 3OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 4United States Nucleic Acid Testing Market Strategies 2015-2020 2US Cancer Vaccine Market Outlook 2020 2US Cancer Vaccine Market Outlook 2020 3
... announced today that they have executed a non-exclusive ... discovery team will apply the technology to explore ... discovery platforms. CompleGen,s XenoGene™ technology uses ... that are selective for specific protein targets. ...
... 16, 2012 /PRNewswire-iReach/ -- Vinod Gupta grew up ... India, where his elderly father still works as a physician. ... United States Gupta realized the American Dream by forming his ... into American Business Information and launched its initial public offering ...
Cached Medicine Technology:B2B Omaha Magazine Features Vin Gupta in Latest Edition Guru Credits Education as the Reason For His Success 2B2B Omaha Magazine Features Vin Gupta in Latest Edition Guru Credits Education as the Reason For His Success 3
(Date:5/28/2015)... The second episode of “Extreme Weight Loss” Season ... need to transform their lives. Josh (29 years old) is ... deal with the death of his father. Kelli (26 years ... MO, who went into depression after her playing career ended. ... featured in one episode of “Extreme Weight Loss” on TUESDAY, ...
(Date:5/27/2015)... NJ (PRWEB) May 28, 2015 Throughout the ... study site for research comparing the validity and reliability of ... Dr. Preeti Nair, P.T., Ph.D., Associate Professor in the Department ... investigator for the study. , The Shaw Gait Assessment is ... piece of equipment. The GaitRite is considered the gold ...
(Date:5/27/2015)... Thermage was the first to come out ... in 2007 coinciding with the release of NXT or CPT, ... Precision Aesthetics was the first practice in New York to ... produced results that had never been achieved before non-surgically. ... still considered by many as the leading skin tightening device. ...
(Date:5/27/2015)... Ticket Down is a reputable source of 2015 ... currently in the middle of their series against the Anaheim Ducks ... If the Blackhawks can win tonight at home, this will tie ... 30th at the Honda Center in Anaheim. , During the ... Western Conference as they won the Pacific Division by 8 points ...
(Date:5/27/2015)... Ticket Down is a reputable source for 2015 Cleveland Cavaliers ... during the 2014-15 NBA season and they delighted their fan base ... of 118-88. , For the Cavaliers, this is their ... lost to the San Antonio Spurs. Once Lebron James joined ... it to the NBA finals increased tenfold. The team had ...
Breaking Medicine News(10 mins):Health News:“Extreme Weight Loss”: Josh and Kelli’s Journeys Begin at the University of Colorado Anschutz Health and Wellness Center 2Health News:“Extreme Weight Loss”: Josh and Kelli’s Journeys Begin at the University of Colorado Anschutz Health and Wellness Center 3Health News:Push to Walk Partners with Seton Hall University for Study 2Health News:Non-Surgical Fat Reduction and Skin Tightening Procedures, Thermage and Exilis, Increase 200% at Precision Aesthetics in New York, April 2015 2Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2Health News:Cavs NBA Finals Tickets: Ticket Down Slashes Ticket Prices on Cleveland Cavaliers 2015 NBA Finals Tickets at Quicken Loans Arena and Offers Valuable Promo Code 2
... could boost death risk, researchers say , , TUESDAY, ... men at high risk for cardiovascular disease, diabetes and ... the odds, according to new studies. , Some ... common with age, are linked to several health conditions. ...
... to the public, agency says , , TUESDAY, June 17 (HealthDay ... letters warning more than two dozen companies to stop selling ... The agency is also cautioning consumers not to buy or ... and creams, and are sold under various names on the ...
... Labs That Are Looking to Place Strategic Bets for the ... ... /Xinhua-PRNewswire/ -- Singapore,s investment of,more than US$2.1 billion in the biomedical sciences ... spending in the,biomedical sciences grew by more than 24% to reach US$760 ...
... Many Have Changed to Health Care & Economic Security ... SPRINGFIELD, Ill., June 17 150 years ago,this ... the,Illinois State Capitol in Springfield. AARP Illinois took the ... issues have changed,the problems of division preventing progress on ...
... Health,Insurance Plans (AHIP) today announced a new ... information technology company, to assist,health insurance plans ... consumers., "This partnership reflects our industry,s ... Health Records," said Charles,Stellar, Executive Vice President ...
... Health,Services, Inc. (Nasdaq: GTIV ), the nation,s leading ... is scheduled to,present from 1:00 to 1:30 p.m. ET, ... Conference in New York., The presentation will be ... which may be accessed by visiting, http://investors.gentiva.com/events.cfm to ...
Cached Medicine News:Health News:Studies Support Testosterone Supplements for Older Men 2Health News:FDA Warns Companies to Stop Selling Fake Cancer Cures 2Health News:FDA Warns Companies to Stop Selling Fake Cancer Cures 3Health News:Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research 2Health News:Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research 3Health News:Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research 4Health News:Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research 5Health News:Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research 6Health News:150 Years Later 'House Divided' Speech Still Holds Strong Message 2Health News:AHIP Selects HealthTrio to Join AHIP Solutions Program 2Health News:Gentiva(R) Health Services to Present June 24 at Jefferies' 2nd Annual Healthcare Conference in New York 2Health News:Gentiva(R) Health Services to Present June 24 at Jefferies' 2nd Annual Healthcare Conference in New York 3
...
...
...
Tip is bent towards port for downward irrigation. 25G x 5/8in (.50 x 22mm)...
Medicine Products: